Cargando…

Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity

Relaxin (RLX) is a protein that is structurally similar to insulin and has interesting biological activities. As with all proteins, preservation of RLX’s structural integrity/biological functionality is problematic. Herein, we investigated two methods for increasing the duration of relaxin-2’s (RLX2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogkos, George, Gkartziou, Foteini, Mourtas, Spyridon, Barlos, Kostas K., Klepetsanis, Pavlos, Barlos, Kleomenis, Antimisiaris, Sophia G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599704/
https://www.ncbi.nlm.nih.gov/pubmed/36291571
http://dx.doi.org/10.3390/biom12101362
_version_ 1784816659126550528
author Kogkos, George
Gkartziou, Foteini
Mourtas, Spyridon
Barlos, Kostas K.
Klepetsanis, Pavlos
Barlos, Kleomenis
Antimisiaris, Sophia G.
author_facet Kogkos, George
Gkartziou, Foteini
Mourtas, Spyridon
Barlos, Kostas K.
Klepetsanis, Pavlos
Barlos, Kleomenis
Antimisiaris, Sophia G.
author_sort Kogkos, George
collection PubMed
description Relaxin (RLX) is a protein that is structurally similar to insulin and has interesting biological activities. As with all proteins, preservation of RLX’s structural integrity/biological functionality is problematic. Herein, we investigated two methods for increasing the duration of relaxin-2’s (RLX2) biological activity: synthesis of a palmitoyl RLX2 conjugate (P-RLX2) with the use of a Palmitoyl-l-Glu-OtBu peptide modifier, and encapsulation into liposomes of P-RLX2, RLX2, and its oxidized form (O-RLX2). For liposomal encapsulation thin-film hydration and DRV methods were applied, and different lipid compositions were tested for optimized protein loading. RLX2 and O-RLX2 were quantified by HPLC. The capability of the peptides/conjugate to stimulate transfected cells to produce cyclic adenosine monophosphate (cAMP) was used as a measure of their biological activity. The stability and bioactivity of free and liposomal RLX2 types were monitored for a 30 d period, in buffer (in some cases) and bovine serum (80%) at 37 °C. The results showed that liposome encapsulation substantially increased the RLX2 integrity in buffer; PEGylated liposomes demonstrated a higher protection. Liposome encapsulation also increased the stability of RLX2 and O-RLX2 in serum. Considering the peptide’s biological activity, cAMP production of RLX2 was higher than that of the oxidized form and the P-RLX2 conjugate (which demonstrated a similar activity to O-RLX2 when measured in buffer, but lower when measured in the presence of serum proteins), while liposome encapsulation resulted in a slight decrease of bioactivity initially, but prolonged the peptide bioactivity during incubation in serum. It was concluded that liposome encapsulation of RLX2 and synthetic modification to P-RLX2 can both prolong RLX2 peptide in vitro stability; however, the applied chemical conjugation results in a significant loss of bioactivity (cAMP production), whereas the effect of liposome entrapment on RLX2 activity was significantly lower.
format Online
Article
Text
id pubmed-9599704
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95997042022-10-27 Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity Kogkos, George Gkartziou, Foteini Mourtas, Spyridon Barlos, Kostas K. Klepetsanis, Pavlos Barlos, Kleomenis Antimisiaris, Sophia G. Biomolecules Article Relaxin (RLX) is a protein that is structurally similar to insulin and has interesting biological activities. As with all proteins, preservation of RLX’s structural integrity/biological functionality is problematic. Herein, we investigated two methods for increasing the duration of relaxin-2’s (RLX2) biological activity: synthesis of a palmitoyl RLX2 conjugate (P-RLX2) with the use of a Palmitoyl-l-Glu-OtBu peptide modifier, and encapsulation into liposomes of P-RLX2, RLX2, and its oxidized form (O-RLX2). For liposomal encapsulation thin-film hydration and DRV methods were applied, and different lipid compositions were tested for optimized protein loading. RLX2 and O-RLX2 were quantified by HPLC. The capability of the peptides/conjugate to stimulate transfected cells to produce cyclic adenosine monophosphate (cAMP) was used as a measure of their biological activity. The stability and bioactivity of free and liposomal RLX2 types were monitored for a 30 d period, in buffer (in some cases) and bovine serum (80%) at 37 °C. The results showed that liposome encapsulation substantially increased the RLX2 integrity in buffer; PEGylated liposomes demonstrated a higher protection. Liposome encapsulation also increased the stability of RLX2 and O-RLX2 in serum. Considering the peptide’s biological activity, cAMP production of RLX2 was higher than that of the oxidized form and the P-RLX2 conjugate (which demonstrated a similar activity to O-RLX2 when measured in buffer, but lower when measured in the presence of serum proteins), while liposome encapsulation resulted in a slight decrease of bioactivity initially, but prolonged the peptide bioactivity during incubation in serum. It was concluded that liposome encapsulation of RLX2 and synthetic modification to P-RLX2 can both prolong RLX2 peptide in vitro stability; however, the applied chemical conjugation results in a significant loss of bioactivity (cAMP production), whereas the effect of liposome entrapment on RLX2 activity was significantly lower. MDPI 2022-09-24 /pmc/articles/PMC9599704/ /pubmed/36291571 http://dx.doi.org/10.3390/biom12101362 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kogkos, George
Gkartziou, Foteini
Mourtas, Spyridon
Barlos, Kostas K.
Klepetsanis, Pavlos
Barlos, Kleomenis
Antimisiaris, Sophia G.
Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title_full Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title_fullStr Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title_full_unstemmed Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title_short Liposomal Entrapment or Chemical Modification of Relaxin2 for Prolongation of Its Stability and Biological Activity
title_sort liposomal entrapment or chemical modification of relaxin2 for prolongation of its stability and biological activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599704/
https://www.ncbi.nlm.nih.gov/pubmed/36291571
http://dx.doi.org/10.3390/biom12101362
work_keys_str_mv AT kogkosgeorge liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT gkartzioufoteini liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT mourtasspyridon liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT barloskostask liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT klepetsanispavlos liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT barloskleomenis liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity
AT antimisiarissophiag liposomalentrapmentorchemicalmodificationofrelaxin2forprolongationofitsstabilityandbiologicalactivity